|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
573,600,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$179.79 - $179.79 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2016-01-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
22,742 |
|
- |
|
| Roberts Margo R |
Chief Scientific Officer |
• – – |
2016-01-15 |
4 |
AS |
$52.49 |
$339,323 |
D/D |
(6,145) |
9,098 |
|
- |
|
| Roberts Margo R |
Chief Scientific Officer |
• – – |
2016-01-15 |
4 |
OE |
$0.70 |
$14,815 |
D/D |
6,145 |
15,243 |
|
- |
|
| Sproule Rizwana F |
VP Regulatory Affairs |
• – – |
2016-01-15 |
4 |
AS |
$52.27 |
$375,589 |
D/D |
(6,800) |
8,741 |
|
- |
|
| Sproule Rizwana F |
VP Regulatory Affairs |
• – – |
2016-01-15 |
4 |
OE |
$1.35 |
$9,180 |
D/D |
6,800 |
15,541 |
|
- |
|
| Better Marc |
VP, Product Sciences |
• – – |
2016-01-04 |
4 |
AS |
$61.09 |
$553,788 |
D/D |
(9,000) |
7,688 |
|
- |
|
| Better Marc |
VP, Product Sciences |
• – – |
2016-01-04 |
4 |
OE |
$0.38 |
$3,420 |
D/D |
9,000 |
16,688 |
|
- |
|
| Butitta Cynthia M |
COO and CFO |
• – – |
2015-12-28 |
4 |
AS |
$61.40 |
$615,599 |
D/D |
(10,000) |
94,007 |
|
- |
|
| Butitta Cynthia M |
COO and CFO |
• – – |
2015-12-28 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
104,007 |
|
- |
|
| Belldegrun Arie |
Chairman, President and CEO |
• • – |
2015-12-21 |
5 |
GD |
$0.00 |
$0 |
I/I |
541,722 |
1,673,750 |
|
- |
|
| Tomasello Shawn |
Chief Commercial Officer |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
44,000 |
54,000 |
|
- |
|
| Better Marc |
VP, Product Sciences |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,800 |
7,688 |
|
- |
|
| Butitta Cynthia M |
COO and CFO |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
94,007 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,400 |
13,742 |
|
- |
|
| Chang David D |
EVP, R&D, Chief Medical Off. |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
25,404 |
|
- |
|
| Roberts Margo R |
Chief Scientific Officer |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,900 |
9,098 |
|
- |
|
| Kim Helen Susan |
EVP, Business Development |
• – – |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,200 |
9,200 |
|
- |
|
| Belldegrun Arie |
Chairman, President and CEO |
• • • |
2015-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
28,200 |
28,200 |
|
- |
|
| Sproule Rizwana F |
VP Regulatory Affairs |
• – – |
2015-12-15 |
4 |
AS |
$62.70 |
$609,994 |
D/D |
(9,567) |
2,941 |
|
- |
|
| Sproule Rizwana F |
VP Regulatory Affairs |
• – – |
2015-12-15 |
4 |
OE |
$1.35 |
$12,915 |
D/D |
9,567 |
12,508 |
|
- |
|
| Roberts Margo R |
Chief Scientific Officer |
• – – |
2015-12-15 |
4 |
AS |
$62.76 |
$391,815 |
D/D |
(6,145) |
2,198 |
|
- |
|
| Roberts Margo R |
Chief Scientific Officer |
• – – |
2015-12-15 |
4 |
OE |
$0.70 |
$14,815 |
D/D |
6,145 |
8,343 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2015-12-15 |
4 |
AS |
$62.64 |
$573,989 |
D/D |
(9,000) |
6,342 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2015-12-15 |
4 |
OE |
$6.89 |
$62,010 |
D/D |
9,000 |
15,342 |
|
- |
|
| Belldegrun Arie |
Chairman, President and CEO |
• • – |
2015-12-10 |
5 |
GD |
$0.00 |
$0 |
I/I |
458,324 |
2,215,472 |
|
- |
|
387 Records found
|
|
Page 11 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
